Cargando…
Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014
BACKGROUND: Resistance to isoniazid is the most common form of drug-resistance in tuberculosis. However only a tiny proportion of TB patients in the world have access to isoniazid drug susceptibility testing—the widely implemented Xpert MTB/RIF technology only tests for resistance to rifampicin. Pat...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279036/ https://www.ncbi.nlm.nih.gov/pubmed/30513085 http://dx.doi.org/10.1371/journal.pone.0206658 |